Improving the Gene Therapy Development Process using Image Cytometry
Many factors and considerations must be optimized to develop the appropriate cell-based assays for gene therapy development.
Many factors and considerations must be optimized to develop the appropriate cell-based assays for gene therapy development.
The microneutralization assay is a powerful, high-throughput screening tool crucial to the efficient development of novel vaccines and the discovery of compounds that can prevent or treat viral disease.
Nexcelom Bioscience provides additional details on how your laboratory can maintain guidelines, meet standards, and ensure proper method selection of counting cells based on your experimentation.
Between preventative vaccines and palliative treatment for the sickest COVID-19 patients lies the realm of existing drugs that could be repurposed for antiviral prophylaxis.
View these simple step-by-step instructions for counting cells using a hemoctyometer and microscope. Includes the formula for calculating the dilution factor.
With labs having to operate with fewer people the ability to increase efficiency has become more important than ever.
We are delighted to announce that, thanks to our loyal customers, the Cellaca™ MX High-throughput Cell Counter has been nominated in the Life Sciences category.
It is important to select the most accurate cell counting method that is fit-for-purpose where cell number and viability significantly affect treatment efficacy.
Available on demand. In this informational webinar, Dr. Dmitry Kuksin, Nexcelom Senior Scientist, examines specific virology related assays such as plaque and foci formation, as well as antibody neutralization.
Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.